Lexaria Bioscience Corp (LEXX)
2.09
-0.07
(-3.24%)
USD |
NASDAQ |
Nov 22, 13:44
Lexaria Bioscience Revenue (Quarterly): 0.084M for May 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
May 31, 2024 | 0.084M |
February 29, 2024 | 0.145M |
November 30, 2023 | 0.1513M |
August 31, 2023 | 0.0307M |
May 31, 2023 | 0.0777M |
February 28, 2023 | 0.02M |
November 30, 2022 | 0.0977M |
August 31, 2022 | 0.1111M |
May 31, 2022 | 0.0997M |
February 28, 2022 | 0.0307M |
November 30, 2021 | 0.0139M |
August 31, 2021 | 0.031M |
May 31, 2021 | 0.2041M |
February 28, 2021 | 0.192M |
November 30, 2020 | 0.2957M |
August 31, 2020 | 0.1337M |
May 31, 2020 | 0.0364M |
February 29, 2020 | 0.0375M |
November 30, 2019 | 0.0103M |
August 31, 2019 | 0.1251M |
May 31, 2019 | 0.0599M |
February 28, 2019 | 0.0153M |
November 30, 2018 | 0.0222M |
August 31, 2018 | 0.0964M |
May 31, 2018 | 0.1403M |
Date | Value |
---|---|
February 28, 2018 | 0.172M |
November 30, 2017 | 0.0246M |
August 31, 2017 | 0.0126M |
May 31, 2017 | 0.0293M |
February 28, 2017 | 0.0126M |
November 30, 2016 | 0.0092M |
August 31, 2016 | 0.0086M |
May 31, 2016 | 0.0062M |
February 29, 2016 | 0.0152M |
November 30, 2015 | 0.0108M |
August 31, 2015 | 0.0046M |
May 31, 2015 | 0.0072M |
February 28, 2015 | 0.0029M |
November 30, 2014 | |
July 31, 2014 | 0.1359M |
April 30, 2014 | 0.1678M |
January 31, 2014 | 0.1601M |
October 31, 2013 | -0.8564M |
July 31, 2013 | 0.2515M |
April 30, 2013 | 0.2534M |
January 31, 2013 | 0.3515M |
October 31, 2012 | 0.469M |
July 31, 2012 | 0.4945M |
April 30, 2012 | 0.1449M |
January 31, 2012 | 0.2494M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0103M
Minimum
Nov 2019
0.2957M
Maximum
Nov 2020
0.0949M
Average
0.084M
Median
May 2024
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -1.782M |
Total Expenses (Quarterly) | 1.827M |
EPS Diluted (Quarterly) | -0.13 |
Enterprise Value | 25.27M |
Profit Margin (Quarterly) | -2.12K% |
Earnings Yield | -21.05% |
Normalized Earnings Yield | -19.85 |